Toxicity trial of canine posterior cricoarytenoid intramuscular vincristine injections

Keyphrases

• Canine 100%
• Posterior Cricoarytenoid muscle 100%
• Posterior Cricoarytenoid 100%
• Histology 66%
• High Dose 66%
• Mucosa 66%
• Recurrent Laryngeal Nerve 66%
• Maximum Tolerated Dose 33%
• Moderate to Severe 33%
• Submucosa 33%
• Local Toxicity 33%
• Treatment Strategy 33%
• After Injection 33%
• Plasma Parameters 33%
• Necrosis 33%
• Human Trials 33%
• Laryngoscope 33%
• Intramuscular Injection 33%
• Direct Laryngoscopy 33%
• Denervated 33%
• Severe Acute 33%
• Total Range of Motion 33%
• Plasma Samples 33%
• Reinnervation 33%
• Vocal Fold Vibration 33%
• Recovery Pattern 33%
• Acute Inflammation 33%
• Target muscle 33%
• Adductor 33%
• Videolaryngoscopy 33%
• Adductor Strength 33%
• Detectable Limit 33%

Veterinary Science and Veterinary Medicine

• Canine 100%
• Posterior Cricoarytenoid Muscle 100%
• Blood Plasma 100%
• Recurrent Laryngeal Nerve 66%
• Muscle 66%
• Mucosa 66%
• Mucous Membrane 66%
• Denervation 33%
• Reinnervation 33%
• Intramuscular Injection 33%
• Intramuscular Drug Administration 33%
• Larynx 33%

Medicine and Dentistry

• Vincristine 100%
• Mucosa 25%
• Drug Megadose 25%
• Recurrent Laryngeal Nerve 25%
• Serositis 12%
• Submucosa 12%
• Vocal Folds 12%
• Necrosis 12%
• Intramuscular Injection 12%
• Laryngoscopy 12%
• Denervation 12%
• Range of Motion 12%
• Reinnervation 12%
• Larynx 12%